Biodesix partners with Thermo Fisher on tumor — naïve MRD blood test program
Biodesix expanded its MRD strategy through collaborations with Bio-Rad for tumor-informed ctDNA monitoring and Thermo Fisher for a tumor-naïve assay. Bio-Rad program uses Droplet Digital PCR to track patient-specific tumor changes in blood, targeting detection below 1 part per million. Thermo Fisher program uses Genexu